Therapeutic application of EUS-guided intraportal autologous bone marrow transplantation for decompensated liver cirrhosis
EUS-guided intraportal ABMT is a safe and highly effective treatment for DLC, demonstrating clear advantages over peripheral infusion due to superior targeting and sustained clinical benefits. The success of ABMT appears to be influenced more critically by the cell delivery route than by the progenitor cell content of the graft.
Authors
- Bing Chen (ORCID: https://orcid.org/0009-0005-0803-1850)
- Yi-cun Shen
- Xin-meng Li
- Lunxi Liang (ORCID: https://orcid.org/0000-0003-4178-9055)
- Xiaoming Liu (ORCID: https://orcid.org/0000-0003-0230-2742)
- Aojian Deng (ORCID: https://orcid.org/0000-0003-4124-0724)
- Yang Liu (ORCID: https://orcid.org/0000-0002-0367-8189)
- Ting Cai (ORCID: https://orcid.org/0000-0001-5926-9280)
- Xiaochen Yang (ORCID: https://orcid.org/0009-0004-8110-9362)
- Fen Wang (ORCID: https://orcid.org/0000-0002-9641-6611)
Institutions
- Central South University (CN)
- Hunan Cancer Hospital (CN)
- Third Xiangya Hospital (CN)
Publication Details
- Journal
- Stem Cell Research & Therapy
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1186/s13287-025-04740-5
- Primary Topic
- Liver physiology and pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Central South University
- Xiangya Hospital, Central South University